Journal of Surgery Concepts & Practice ›› 2018, Vol. 23 ›› Issue (03): 286-288.doi: 10.16139/j.1007-9610.2018.03.020
• Review • Previous Articles Next Articles
Received:2018-02-08
Published:2020-07-25
CLC Number:
| [1] Yeh SH, Chen PJ, Shau WY, et al.Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma[J]. Gastroenterology,2001,121(3):699-709. [2] Niller HH, Ay E, Banati F, et al.Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms[J]. Rev Med Virol,2016,26(1):57-73. [3] Feitelson MA, Sun B, Satiroglu Tufan NL, et al.Genetic mechanisms of hepatocarcinogenesis[J]. Oncogene,2002, 21(16):2593-2604. [4] Bosman FT, Carneiro F, Hruban RH, et al.WHO Classification of Tumours of the Digestive System[M]. 4th Edi-tion. Lyon: IARC press, 2010. [5] 陈伶俐. 肝脏异型增生结节癌变过程的病理形态、发生机制及癌变相关microRNA的研究[D]. 上海: 复旦大学,2011. [6] 丛文铭, 朱世能. 肝胆肿瘤病理学[M]. 上海: 上海科技教育出版社,2015. [7] Lim JH, Kim MJ, Park CK, et al.Dysplastic nodules in liver cirrhosis: detection with triple phase helical dyna-mic CT[J]. Br J Radiol,2004,77(923):911-916. [8] Bansal N, Vij V, Rastogi M.Different nodules identified during liver explant gross examination: relevance and need for sectioning-experience from India[J]. Int J Hepatol,2016,2016:4390434. [9] Yazdanpanah S, Geramizadeh B, Nikeghbalian S, et al.Hepatocellular carcinoma and its precursors in 103 HBV-related cirrhotic explanted livers: A study from south Iran[J]. Hepat Mon,2016,16(8):e38584. [10] International Working Party.Terminology of nodular he-patocellular lesions[J]. Hepatology,1995,22(3):983-993. [11] International Consensus Group for Hepatocellular Neoplasia the International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia[J]. Hepatology,2009, 49(2):658-664. [12] Park YN, Kojiro M, Di Tommaso L, et al.Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules[J]. Cancer,2007,109(5):915-923. [13] Sciarra A, Di Tommaso L, Nakano M, et al.Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications[J]. J Hepatol,2016,64(1):87-93. [14] Paschoal JP, Bernardo V, Canedo NH, et al.Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression[J]. BMC Cancer,2014,14:72. [15] Kudo M.Multistep human hepatocarcinogenesis: correlation of imaging with pathology[J]. J Gastroenterol,2009, 44(19):112-118. [16] Serste T, Barrau V, Ozenne V, et al.Accuracy and dis-agreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy[J]. He-patology,2012,55(3):800-806. [17] Kojiro M.Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West[J]. Hepatol Res,2007,37(Suppl 2):S121-S124. [18] Di Tommaso L, Franchi G, Park YN, et al.Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis[J]. Hepatology,2007, 45(3):725-734. [19] Cai MY, Tong ZT, Zheng F, et al.EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies[J]. Gut,2011, 60(7):967-976. [20] Yao DF, Dong ZZ, Yao M.Specific molecular markers in hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int,2007,6(3):241-247. [21] Jin GZ, Li Y, Cong WM, et al.iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma[J]. J Proteome Res,2011, 10(8):3418-3428. [22] Di Tommaso L, Sangiovanni A, Borzio M, et al.Advanced precancerous lesions in the liver[J]. Best Pract Res Clin Gastroenterol,2013,27(2):269-284. [23] Borzio M, Fargion S, Borzio F, et al.Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development[J]. J Hepatol,2003,39(2):208-214. [24] Kobayashi M, Ikeda K, Hosaka T, et al.Dysplastic no-dules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis[J]. Cancer,2006,106(3):636-647. [25] Seki S, Sakaguchi H, Kitada T, et al.Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study[J]. Clin Cancer Res,2000,6(9):3469-3473. [26] Okuda T, Wakasa K, Kubo S, et al.Clonal analysis of hepatocellular carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene[J]. Cancer Lett,2001,164(1):91-96. [27] Aihara T, Noguchi S, Sasaki Y, et al.Clonal analysis of precancerous lesion of hepatocellular carcinoma[J]. Gastroenterology,1996,111(2):455-461. [28] Paradis V, Laurendeau I, Vidaud M, et al.Clonal analysis of macronodules in cirrhosis[J]. Hepatology,1998,28(4):953-958. [29] Sun M, Eshleman JR, Ferrell LD, et al.An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region[J]. Hepatology,2001,33(6):1415-1424. [30] Nam SW, Park JY, Ramasamy A, et al.Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling[J]. Hepatology,2005,42(4):809-818. [31] Kang HJ, Chung DH, Sung CO, et al.SHP2 is induced by the HBx-NF-kappaB pathway and contributes to fibrosis during human early hepatocellular carcinoma development[J]. Oncotarget,2017,8(16):27263-27276. [32] Shim YH, Yoon GS, Choi HJ, et al.p16 Hypermethylation in the early stage of hepatitis B virus-associated he-patocarcinogenesis[J]. Cancer Lett,2003,190(2):213-219. [33] Frau M, Feo F, Pascale RM.Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis[J]. J He-patol,2013,59(4):830-841. |
| [1] | ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482. |
| [2] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 221-228. |
| [3] | CHEN Congyan, WANG Junqing, CHEN Yongjun. Gut microbiota and mechanism of liver cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 256-260. |
| [4] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94. |
| [5] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 95-99. |
| [6] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106. |
| [7] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 107-112. |
| [8] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 113-118. |
| [9] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 119-122. |
| [10] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 123-127. |
| [11] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130. |
| [12] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 131-133. |
| [13] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 134-138. |
| [14] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 139-144. |
| [15] | ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti. Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 152-157. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
